Characterisation and outcome of RAC1 mutated melanomaGeorg Lodde, Klaus Griewank, Jens Ulrich et al.|European Journal of Cancer|2023Cited by 14
Early versus late response to PD-1-based immunotherapy in metastatic melanomaGeorg Lodde, Selma Ugurel, Fang Zhao et al.|European Journal of Cancer|2024Cited by 9
Characterization and Outcome of RAC1 Mutated MelanomaGeorg Lodde, Klaus Griewank, Philipp Jansen et al.|SSRN Electronic Journal|2022Cited by 0